Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 4913 (116th)

To amend title XVIII of the Social Security Act to require PDP sponsors of a prescription drug plan under part D of the Medicare program that use a formulary to include certain generic drugs and biosimilar biological products on such formulary, and for other purposes.

referredUnited States· United States Congress· EN

Introduced

30 October 2019

Last action

30 October 2019 · Introduced

Status

Referred to the Subcommittee on Health.

Sponsors

Rep. McKinley, David B. [R-WV-1], Rep. Kuster, Ann M. [D-NH-2], Sen. Welch, Peter [D-VT], Rep. Olson, Pete [R-TX-22], Sen. Budd, Ted [R-NC], Rep. Tonko, Paul [D-NY-20], Rep. Joyce, David P. [R-OH-14], Rep. Soto, Darren [D-FL-9], Rep. Carter, Earl L. "Buddy" [R-GA-1], Rep. Craig, Angie [D-MN-2], Rep. Bass, Karen [D-CA-37], Rep. Carbajal, Salud O. [D-CA-24], Rep. Reschenthaler, Guy [R-PA-14], Rep. Rush, Bobby L. [D-IL-1], Rep. Matsui, Doris O. [D-CA-7], Rep. Ruiz, Raul [D-CA-25], Anthony Gonzalez, Rep. Garamendi, John [D-CA-8], Rep. Mooney, Alexander X. [R-WV-2], Rep. Gooden, Lance [R-TX-5], Rep. McMorris Rodgers, Cathy [R-WA-5], Rep. Lawrence, Brenda L. [D-MI-14]

Subjects

Healthcare

Source updated

7 April 2025

Healthcare

Official sourceDownload fileView documentsShare

Summary

This bill establishes additional requirements for prescription drug plan (PDP) sponsors that use formularies under the Medicare prescription drug benefit. Specifically, the bill requires PDP formularies to include covered generic drugs and biosimilars for which the wholesale acquisition cost is less than that of the reference (i.e., brand-name) product. PDP sponsors must also establish specific cost-sharing tiers that apply lower cost-sharing requirements for such covered generic drugs and biosimilars as compared to those for brand-name products. The bill also prohibits PDP sponsors from instituting certain requirements relating to access to such covered generic drugs and biosimilars that are more restrictive than those for brand-name products (e.g., prior authorization requirements).

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 30 October 2019

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

  2. 30 October 2019

    Introduced

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Source: IntroReferral

  3. 30 October 2019

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 30 October 2019

    Introduced

    Introduced in House

    Source: IntroReferral

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House (text)

    Introduced in House · EN · 30 October 2019

    ViewDownloadOpen at official source

  • Introduced in House (PDF)

    Introduced in House · EN · 30 October 2019

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House

    summary · EN · 30 October 2019

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Related records

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.